TIDMUDG

RNS Number : 6463M

UDG Healthcare Public Limited Co.

01 May 2018

1 May 2018

UDG Healthcare plc

Notice of Interim Results

UDG Healthcare plc ("the Group"), a leading international healthcare services provider, will issue its interim results for the half year ended 31 March 2018 at 07:00am (BST) on Tuesday 22 May 2018.

Management will be hosting a presentation for analysts and investors at the London Stock Exchange at 08:30am (BST) to discuss the company's half year results and provide an update on each of the Group's divisions.

Analysts and investors wishing to attend are asked to contact Powerscourt on the details below, as all attendees need to be pre-registered. The presentation will also be available via live audio webcast and conference call, the details of which are below.

Audio webcast:

https://edge.media-server.com/m6/p/hporn254

Conference call dial-in details:

 
 UK                          +44 (0)330 336 9105 
--------------------------  -------------------- 
 Ireland                     +353 (0)1 246 5638 
--------------------------  -------------------- 
 United States of America    +1 929-477-0448 
--------------------------  -------------------- 
 Participant Code            6327399 
--------------------------  --------------------

For further information, please contact:

 
 UDG Healthcare plc 
  Keith Byrne 
 Head of Investor Relations, Strategy 
  & Corporate Communications 
 Tel: +353-1-468-9000 
 
 Powerscourt 
 Lisa Kavanagh / Isabelle Saber / 
  Sam Austrums 
 Tel: +44-207-250-1446 
  udghealthcare@powerscourt-group.com

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing 9,000 people with operations in 24 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across three divisions: Ashfield, Sharp and Aquilant.

Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across three areas of activity: advisory, communication, commercial & clinical services. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. Ashfield provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial supply chain solutions services for the pharmaceutical and biotechnology industries, operating from state-of-the-art facilities in the US and Europe.

Aquilant is leading distributor of specialist medical and scientific products, providing outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information, please go to: www.udghealthcare.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORSDLFMSFASEEL

(END) Dow Jones Newswires

May 01, 2018 02:00 ET (06:00 GMT)

Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Udg Healthcare Public Charts.
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Udg Healthcare Public Charts.